# Wavelet Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wavelet-medical

- Industry: Medical Devices & Equipment
- Headquarters: New Haven, US
- Website: www.wavelet.co
- Total disclosed funding: $7M
- Latest round: Seed (Apr 14, 2026)
- Investors on record: 1

## About

Wavelet Medical, based in the US, focuses on developing innovative medical technology solutions aimed at enhancing fetal brain monitoring and improving healthcare outcomes through data-driven insights.Wavelet Medical was founded in 2024 in New Haven, US, and is dedicated to developing advanced fetal brain monitoring technologies. The company has secured USD 7.000 mn in Seed funding from Aegis Ventures as of April 2026, marking its first significant investment round, which has facilitated its initial expansion efforts.Wavelet specializes in providing advanced technology solutions that enhance data processing and analytics capabilities for businesses across various sectors. Their core offerings include a suite of software products designed to improve operational efficiency and decision-making through real-time data insights. These solutions are designed for a diverse client base that includes enterprises in technology, finance, and healthcare, among others. Wavelet's software is tailored to address specific challenges, such as optimizing resource allocation, increasing customer engagement, and enabling predictive analytics. The products are currently available in key geographical markets, including North America, Europe, and parts of Asia, positioning Wavelet as a competitive player in the global data solutions landscape.Wavelet’s revenue model is structured around a subscription-based service that provides clients with continuous access to its software offerings. Businesses typically enter into annual contracts that provide tiered access to various features depending on their individual needs, allowing for customized engagement based on company size and industry requirements. The transactions are primarily B2B, with clients ranging from small startups to large enterprises, who utilize Wavelet's products to streamline operations and enhance data-driven strategies. Pricing plans are designed to accommodate different scales of use, enabling businesses to select packages that align with their operational goals. Specific flagship products are integral to the company’s revenue generation, establishing Wavelet as a trusted partner in its clients’ digital transformation journeys.In April 2026, Wavelet Medical raised USD 7.000 mn in Seed funding to support its growth and further development of its Fetal Brain Monitoring technology. The company plans to launch new products designed specifically for enhanced monitoring solutions by the end of 2026, while also targeting expansion into Europe and Asia by 2027.

## Funding rounds

- Seed, Apr 14, 2026, $7M — Aegis Ventures

## Investors

- Aegis Ventures (https://capitalatlas.ai/funds/aegis-ventures) — Seed